AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2014
Oct 31, 2014
30016_dirs_2014-10-31_ca36f569-3ee4-4e85-ba79-fcf872e45c89.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-10-29
Reporting Person: MCKEON BRIAN P (Executive VP, CFO & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-10-29 | Common Stock | M | 2934 | $56.95 | Acquired | 15275 | Direct |
| 2014-10-29 | Common Stock | S | 2934 | $142.17 | Disposed | 12341 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-10-29 | Non-Qualified Stock Option (right to buy) | $56.95 | M | 2934 | Disposed | 2015-02-13 | Common Stock (2934) | Direct |
Footnotes
F1: The sale reported above was effected pursuant to a Rule 10b5-1 trading plan (the "Plan") adopted by the reporting person on 02/20/2014. The Plan covers certain stock options held by the reporting person that will expire in 2014 and 2015 and will permit the sale of the shares received upon the exercise of such stock options and the payment of the applicable exercise prices and taxes due upon the exercise of such stock options.
F2: Grant of options to buy shares of common stock that vested on 02/14/2009.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 26